Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
Acuren Corp
NYSE:TIC
|
US |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
ContextVision AB
OSE:CONTX
|
SE |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
Artisanal Spirits Company PLC
LSE:ART
|
UK |
|
United Fire Group Inc
NASDAQ:UFCS
|
US |
Wall St Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 9 137.35 JPY with a low forecast of 7 160.9 JPY and a high forecast of 11 550 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cosmos Pharmaceutical Corp's stock price target?
Price Target
9 137.35
JPY
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 9 137.35 JPY with a low forecast of 7 160.9 JPY and a high forecast of 11 550 JPY.
What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 10%.
What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.
